Abstract
Many diseases candidates for gene therapy require that the therapeutic gene expression level is controlled in order to ensure biological efficacy and to prevent toxic effects. Various systems have been described which allow transcriptional regulation by artificial chimeric transactivators in mammalian cells. This paper describes the tetracycline regulatable systems and discuss their potential application for gene therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackland-Berglund, C. E., and Leib, D. A. (1995). Efficacy of Tetracycline-Controlled Gene Expression is Influenced by Cell Type. BioTechniques 18, 196–200.
Agarwal, M. L., Agarwal, A., Taylor, W. R., and Stark, G. R. (1995). p53 controls both the G2/M and the G1 cell cycle checkpoint and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92, 8493–8497.
Blanchard, K. L., Acquaviva, A. M., Galson, D. L., and Bunn, H. F. (1992). Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol. Cell. Biol. 12, 5373–5385.
Blau, C. A., Peterson, K. R., Drachman, J. G., and Spencer, D. M. (1997). A proliferation switch for genetically modified cells. Proc. Natl. Acad. Sci. 94, 3076–3081.
Bohl, D., and Heard, J. (1997). Modulation of erythropoietin delivery from engineered muscles in mice. Human Gene Ther. 8, 195–204.
Bohl, D., Naffakh, N., and Heard, J. M. (1997). Long term control of erythropoietin secretion levels by tetracycline in mice transplanted with engineered primary myoblasts. Nature Med. 3, 299–312.
Cao, J., Park, I., Cooper, A., and Sodroski, J. (1996). Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J. Virol. 70, 1340–1354.
Cayrot, C., and Flemington, E. K. (1995). Identification of cellular target genes of the Epstein-Barr virus transactivator Zta activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-betal. J. Virol. 69, 206–212.
Cox, L. A., and Adrian, G. S. (1993). Posttranscriptional regulation of chimeric human transferrin genes by iron. Biochemistry 32, 4738–4745.
Davis, J. L., Gross, P. R., and Danos, O. (1997). Development and characterization of a translationally regulated retroviral vector. Abstract, Keystone Meeting, April 13–19, 21.
Degenkolb, J., Takahashi, M., Ellestad, G. A., and Hillen, W. (1991). Structural requirements of tetracycline-tet repressor interaction: determination of equilibrim binding constants for tetracycline analogs with the tet repressor. Antimicrob. Agents Chemother. 35, 1591–1595.
Delort, J. P., and Capecchi, M, R. (1996). TAXI/UAS: a molecular switch to control expression of gens m vivo. Hum. Gene Ther. 7, 809–820.
Deuschle, U., Meyer, W. K.-H., and Thiesen, H.-J. (1995). Tetracycline-Reversible Silencing of Eukaryotic Promoters. Mol. Cell. Biol. 15, 1907–1914.
Dingermann, T., Frank-Stoll, U., Werner, H., Wissman, A., Hillen, W., Jacquet, M., and Marschalek, R. (1992). RNA polymerase III catalysed transcription can be regulated in Saccharomyces cerevisiae by the bacterial tetracycline repressor-operator system. EMBO J. 11, 1487–1492.
Dingermann, T., Werner, H., Schütz, A., Zündorf, I., Nerke, K., Knecht, D., and Marschalek, R. (1992). Establishment of a system for conditional gene expression using an inducible tRNA suppressor gene. Mol. Cell. Biol. 12, 4038–4045.
Efrat, S., Fusco-DeMane, D., Lemberg, H., Al Emran, O., and Wang, X. (1995). Conditional transformation of a pancreatic b-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc. Natl. Acad. Sci. USA 92, 3576–3580.
Emerman, M., and Temin, H. M. (1984). Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39, 459–467.
Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D., and Chambon, P. (1996). Ligand-activated site-specific recombinasion in mice. Proc. Natl. Acad. Sci. 93, 10887–10890.
Fishman, G. I., Kaplan, M. L., and Buttrick, P. M. (1994). Tetracycline-regulated cardiac gene expression in vivo. J. Clin. Invest. 93, 1864–1868.
Freiberg, R. A., Ho, S. N., and Khavari, P. A. (1997). Transcriptional control in keratinocytes and fibroblasts using synthetic ligands. J. Clin. Invest. 99, 2610–2615.
Freiberg, R. A., Spencer, D. M., Choate, K. A., Peng, P. D., Schreiber, S. L., Crabtree, G. R., and Khavari, P. A. (1996). Specific triggering of the fas signal transduction pathway in normal human keratinocytes. J. Biol. Chem. 271, 31666–31669.
Furth, P. A., St. Onge, L., Böger, H., Grass, P., Gossens, M., Kistner, A., Bujard, H., and Hennighausen, L. (1994). Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91, 9302–9306.
Gatz, C., Kaiser, A., and Wendenburg, R. (1991). Regulation of a modified CaMV 35S promoter by the Tn10- encoded Tet repressor in transgenic tobacco. Mol. Gen. Genet. 227, 229–237.
Goossen, B., Wright Caughman, S., Harford, J. B., Klausner, R. D., and Hentze, M. W. (1990). Translational repression by a complex between the iron-responsive element of ferritin mRNA and its specific cytoplasmic binding protein is position dependent in vivo. EMBO J. 9, 4127–4133.
Gossen, M., and Bujard, H. (1993). Anhydrotetracyclin, a novel effector for tetracycline controlled gene expression in eukaryotic cells. Nucl. Acid Res. 21, 4411–4412.
Gossen, M., and Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547–5551.
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., and Bujard, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766–1769.
Ho, D. Y., McLaughlin, J. R., and Sapolsky, R. M. (1996). Inducible gene expression from defective herpes simplex virus vectors using tetracycline-responsive promoter system. Mol. Brain Res. 41, 200–209.
Hoffman, A., Nolan, G., and Blau, H. B. (1996). Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. USA 93, 5185–5190.
Hoshimaru, M., Ray, J., Sah, D. W. Y., and Gage, F. H. (1996). Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc. Natl. Acad. Sci. USA 93, 1518–1523.
Howe, J. R., Skryabin, B. V., Belcher, S. M., Zerillo, C. A., and Sclimauss, C. (1995). The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J. Biol. Chem. 270, 14168–14178.
Hu, M. C. T., and Davidson, N. (1990). A combination of derepression of the lac operator-repressor system with positive induction by glucocorticoid and metal ions provides a high-level-inducible gene expression system based on the human metallothionein-IIA promoter. Mol. Cell. Biol. 10, 6141–6451.
Hwang, J. J., Scuric, Z., and Anderson, W. F. (1996). Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracyclineresponsive expression system. J. Virol. 70, 8138–8141.
Iida, A., Chen, S. T., Friedmann, T., and Yee, J. K. (1996). Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J. Virol. 70, 6054–6059.
Ingles, C. J., Shales, M., Cress, W. D., Triezenberg, S. J., and Greenblatt, J. (1991). Reduced Binding of TFID to Transcriptionally compromised Mutants of VP16. Nature 351, 588–590.
Israel, D., and Kaufman, R. J. (1989). Highly Inducible Expression From Vectors Containing Multiple GRE’s in CHO Cells Overexpressing the Glucocorticoid Receptor. Nucleic. Acids. Res. 17, 4589–4604.
Jiang, B., Rue, E., Wang, G. L., Roe, R., and Semenza, G. L. (1996). Dimerization, DNA binding and transactivation properties of hypoxia-inducible factor 1. J. Bio. Chem. 271, 17771–17778.
Kenan, D. J., Tasi, D. E., and Keene, J. D. (1994). Exploring molecular diversity with combinatorial shape libraries. TIBS 19, 57–64.
Kim, H. J., Gatz, C., Hillen, W., and Jones, T. R. (1995). Tetracycline repressor-regulated gene repression in recombinant human cytomegalovirus. J. Virol. 69, 2565–2573.
Lin, Y.-S., Ha, I., Maldonado, E., Reinberg, D., and Green, M. R. (1991). Binding of General Transcription Factors TFIIB to an Acidic Activating Region. Nature 353, 569–571.
Madan, A., and Curtin, P. T. (1993). A 24-base-pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc. Natl. Acad. Sci. USA 90, 3928–3932.
Mader, S., and White, J. S. (1993). A Steroid-Inducible Promoter for the Controlled Overexpression of Cloned Genes in Eukaryotic Cells. Proc. Natl. Acad. Sci. USA 90, 5603–5607.
Mahfoudi, A., Roulet, E., Dauvois, S., Parker, M. G., and Whali, W. (1995). Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc. Natl. Acad. Sci. 92, 4206–4210.
Mayo, K. E., Warren, R., and Palmiter, R. D. (1982). The Mouse Metallothionein-I Gene Is Transcriptionally Regulated by Cadmium Following Transfaction into Human or Mouse Cells. Cell 29, 99–108.
No, D., Yao, T., and Evans, R. M. (1996). Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. 93, 3346–3351.
Passman, R. S., and Fishman, G. I. (1994). Regulated expression of foreign genes in vivo after germline transfer. J. Clin. Invest. 94, 2421–2425.
Paulus, W., Baur, I., Boyce, F. M., Breakefield, X. O., and Reeves, S. A. (1996). Self-contained, tetracyclineregulated retroviral system for gene delivery to mammalian cells. J. Virol. 70, 62–67.
Resnitzky, D., Hengst, L., and Reed. S. I. (1995). Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kipl. Mol. Cell. Biol. 15, 4347–4352.
Rivera, V. M., Clackson, T., Natesan, S., Pollock, R., Amara, J. F., Keenan, T., Magari, S. R., Phillips, T., Courage, N. L., Cerasoli, F., Dennis, A. H., and Gilman, M. (1996). A humanized system for pharmacologic control of gene expression. Nat. Med. 2, 1028–1032.
Rizzino, A., and Miller, K. (1995). The function of inducible promoter systems in F9 embryonal carcinoma cells. Exp. Cell Res. 218, 144–150.
Röder, F. T., Schmülling, T., and Gatz, C. (1994). Efficiency of the tetracycline-dependent gene expression system: complete suppression and efficient induction of the rolB phenotype in transgenic plants. Mol. Gen. Genet. 243, 32–38.
Schaack, J., Guo, X., Ho, Y., Karlok, M., Chen, C., and Oemelles, D. (1995). Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines. J. Virol. 69, 4079–4085.
Schultze, N., Burki, Y., Lang, Y., Certa, U., and Bluethmann, H. (1996). Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nature Biotech. 14, 499–505.
Schweinfest, C. W., Jorcyk, C. L., Fujiwara, S., and Papas, T. S. (1988). A heat-shock inductible eukaryotic expression vector. Gene 71, 207–210.
Searl, P. F., Stuart, G. W., and Palmiter, R. D. (1985). Building a Metal-Responsive Promoter With Synthetic Regulatory Elements. Mol. Cell. Biol. 5, 1480–1489.
Shan, B., and Lee, W. (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell Biol. 14, 8166–8173.
Shockett, P., Difilippantonio, M., Heilman, N., and Schatz, D. (1995). A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 92, 6522–6526.
Spencer, D. M., Beishaw, P. J., Chen, L., Ho, S. N., Randazzo, F., Crabtree, G. R., and Schreiber, S. L. (1996). Functional analysis of fas signaling in vivo using synthetic inducers of dimerization. Current Biol. 6, 839–847.
Staeheli, P., Danielson, P., Haller, O., and Sutcliffe, J. G. (1986). Transcriptional activation of the mouse Mx gene by type 1 interferon. Mol. Cel. Biol. 6, 4770–4774.
Totzke, F., Marmé, D., and Hug, R. (1992). Inducible expression of human phospholipase C-g2 and its activation by platelet-derived growth factor B-chain homodimer and platelet-derived growth factor A-chain homodimer in transfected NIH 3T3. Eur. J. Biochem. 203, 633–639.
Triezenberg, S. J., Kingsbury, R. C., and McKnight, S. L. (1988). Functional Dissection of VP16, the Trans- Activator of Herpes Simplex Virus Immediate Early Gene Expression. Genes and development 2, 718–729.
Wang, G. L., and Semenza, G. L. (1993). General involvment of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90, 4304–4308.
Wang, Y., O’Malley Jr., B. W., Tasai, S. Y., and O’Malley, B. W. (1994). A regulatory system for use in gene transfer. Proc Natl. Acad. Sci. USA 91, 8180–8184.
Watsuji, T., Okamoto, Y., Emi, N., Katsuoka, Y., and Hagiwara, M. (1997). Controlled gene expression with a reverse tetracycline-regulated retroviral vector system. Bioche. Biophys. Res. Comm. 234, 769–773.
Wimmel, A., Lucibello, F. C., Sewing, A., Adolph, S., and Muller, R. (1994). Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 9, 995–997.
Wirtz, E., and Clayton, C. (1995). Inducible gene expression in trypanosomes mediated by a prokaryotic repressor. Science 268, 1179–1183.
Wurm, F. M., Gwinn, K. A., and Kingston, R. E. (1986). Inducible overexpression of a mouse c-myc protein in mammalian cells. Proc. Natl. Sci. 83, 5414–5418.
Xu, L., Yee, J. K., Wolff, J. A., and Friedmann, T. (1989). Factors influencing long-term stability of Moloney leukemia virus-based vectors. Virology 171, 331–341.
Yarranton, G. T. (1992). Inducible vectors for expression in mammalian cells. Cur. Op. in Biotech. 3, 506–511.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bohl, D., Heard, JM. (1998). Application of Tetracycline Regulatable Systems for Gene Therapy. In: Xanthopoulos, K.G. (eds) Gene Therapy. NATO ASI Series, vol 105. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72160-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-72160-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72162-5
Online ISBN: 978-3-642-72160-1
eBook Packages: Springer Book Archive